Figure 5
From: Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway
(A) The anti-tumor effect of PTS in the GBC-SD xenograft model. Body weights of GBC-SD xenograft-bearing mice after PTS treatment. Tumor weights and size of GBC-SD xenografts treated with PTS. (B) Expression of PI3K, p-PI3K, Akt and p-Akt protein in GBC-SD xenografts. (C) A proposed model for how PI3K/Akt/β-catenin signaling mediates EMT in GBC-SD cells. *P < 0.05; **P < 0.01, compared with the control group.
